# Epidemiological features of hypermucoviscous Klebsiella pneumoniae infection in a coastal city of China: clinical and molecular perspectives

**Authors:** Fengzhen Yang, Lingyan Hou, JinCheng Rong, Xiaohui Chi, Qi Zhao, Maoli Yi

PMC · DOI: 10.3389/fcimb.2026.1732291 · Frontiers in Cellular and Infection Microbiology · 2026-02-09

## TL;DR

This study examines the clinical and genetic features of hypermucoviscous Klebsiella pneumoniae infections in Yantai, China, identifying common strains and virulence factors.

## Contribution

The study identifies dominant clones and virulence genes in hypermucoviscous Klebsiella pneumoniae isolates in Yantai, China.

## Key findings

- Hypermucoviscous Klebsiella pneumoniae (hmKP) accounted for 18.1% of isolates in Yantai.
- K1/ST23 and K2/ST65 clones were predominant among hmKP isolates.
- Two hypervirulent carbapenem-resistant Klebsiella pneumoniae (HCKP) strains were detected.

## Abstract

The present study aimed to investigate the overall clinical and molecular characteristics of hypermucoviscous Klebsiella pneumoniae (hmKP) infection in Yantai, China.

A retrospective study was conducted in Yantai Yuhuangding Hospital from October 2024 to December 2024. As the inclusion criterion, all clinical isolates of K. pneumoniae were analyzed by a string test, in which an inoculation loop was used to generate sticky strings of >5 mm length from a K. pneumoniae colony. The isolates showing a positive test result were designated as hmKP. The clinical characteristics of patients with hmKP infection were retrospectively reviewed. Antibiotic susceptibility tests were performed for all hmKP isolates, and whole-genome sequencing studies were conducted for these isolates to determine their epidemiological characteristics.

A total of 88 unique hmKP isolates were collected from 485 strains of K. pneumoniae, accounting for 18.1%. Patients with hmKP infection were distributed across different age groups, clinical departments, and specimen types. Whole-genome sequencing revealed the predominance of K1/ST23 and K2/ST65 clones in the hmKP group. Virulence determinants such as rmpA, rmpA2, iuc, iro, peg-344, and clb were commonly present in the hmKP isolates. All hmKP isolates carried multiple resistance genes; however, the antibiotic resistance phenotype did not fully match with the resistance genes. Additionally, two hypervirulent carbapenem-resistant Klebsiella pneumoniae(HCKP) strains were detected in this study.

HmKP infection is prevalent in Yantai, China, with dominant K1/ST23 and K2/ST65 clones carrying prevalent virulence genes. Vigilance is required to prevent the spread of HCKP in clinical practice.

## Linked entities

- **Genes:** iro (ribosome associated inhibitor A; zinc finger domain) [NCBI Gene 14181455], CLYBL (citramalyl-CoA lyase) [NCBI Gene 171425]
- **Species:** Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Genes:** UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** K. pneumoniae infection (MESH:D011014), liver abscess (MESH:D008100), inflammatory (MESH:D007249), malignant tumor (MESH:D009369), diabetes (MESH:D003920), HCKP (MESH:D007710), infectious diseases (MESH:D003141), Hypertension (MESH:D006973), bacteremia (MESH:D016470), HmKP infection (MESH:D007239), urinary tract infections (MESH:D014552)
- **Chemicals:** meropenem (MESH:D000077731), cefepime (MESH:D000077723), levofloxacin (MESH:D064704), CAZ (MESH:D002442), carbapenem (MESH:D015780), gentamicin (MESH:D005839), tobramycin (MESH:D014031), allantoin (MESH:D000481), FEP (MESH:D011138), yersiniabactin (MESH:C104398), enterobactin (MESH:D004758), amoxicillin/clavulanic acid (MESH:D019980), polysaccharide (MESH:D011134), ciprofloxacin (MESH:D002939), ampicillin/sulbactam (MESH:C035444), imipenem (MESH:D015378), cefotetan (MESH:D015313), agarose (MESH:D012685), trimethoprim/sulfamethoxazole (MESH:D015662), cefazolin (MESH:D002437), lipopolysaccharides (MESH:D008070), beta-lactam (MESH:D047090), AMK (-), fosfomycin (MESH:D005578), ATM (MESH:C020809), aztreonam (MESH:D001398), salmochelin (MESH:C000630262), aerobactin (MESH:C031819), cefuroxime (MESH:D002444), piperacillin/tazobactam (MESH:D000077725), ceftriaxone (MESH:D002443), cephalosporins (MESH:D002511), quinolone (MESH:D015363), amikacin (MESH:D000583)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926502/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12926502/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926502/full.md

---
Source: https://tomesphere.com/paper/PMC12926502